{"id":"W2994893487","doi":"10.1016/j.jval.2019.09.597","title":"PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN REIMBURSEMENT FOR SELECT NOVEL CANCER THERAPEUTICS IN CANADA, ITALY, AND AUSTRALIA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Reimbursement; Crizotinib; Ipilimumab; Medicine; Trastuzumab; Family medicine; Cancer; Oncology; Health care; Internal medicine; Breast cancer; Lung cancer; Economic growth","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003406853,0.0001860268,0.0004007047,0.001607511,0.001128638,0.002439878,0.0009431743,0.001043878,0.002197661],"category_scores_gemma":[0.02271338,0.0003363358,0.0006378587,0.003251221,0.001259985,0.0006410189,0.001735603,0.002352052,0.0001066772],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06662549,"about_ca_system_score_gemma":0.06291673,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9646559,"about_ca_topic_score_gemma":0.9708482,"domain_scores_codex":[0.9959722,0.0007485736,0.0002330902,0.0002458513,0.001487659,0.001312565],"domain_scores_gemma":[0.9764721,0.003706246,0.005374205,0.000366163,0.006424773,0.007656613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002134488,0.0002498728,0.8733659,0.0003297979,0.0004348096,0.0009524233,0.002270964,0.00515599,0.0004409052,0.01183636,0.03456941,0.06825911],"study_design_scores_gemma":[0.00008885933,0.0001363347,0.9834483,0.0001585464,0.00009290308,0.0002164803,0.001761598,0.003473351,0.0001016964,0.0004786642,0.01000489,0.00003836363],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9540702,0.004806316,0.0002210487,0.02604433,0.0001248397,0.00006912806,0.003610975,0.00001672968,0.0110364],"genre_scores_gemma":[0.9933854,0.00169631,0.0002056621,0.001245379,0.00005647295,0.00003435713,0.001024302,0.00001317789,0.002339031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9333745,"threshold_uncertainty_score":0.483404,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.60011601143961,"score_gpt":0.4933354986417834,"score_spread":0.1067805127978266,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}